Center-Authored Papers

Filters: Author is Paczesny, Sophie  [Clear All Filters]
2008
Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda EA, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G et al..  2008.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.. Journal of proteome research. 7(4):1481-9. Abstract
2009
Katayama H, Paczesny S, Prentice RL, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J et al..  2009.  Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.. Genome medicine. 1(4):47. Abstract
Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, Busald Buson T, Paczesny S, Katayama H, Wang H, Johnson MM et al..  2009.  Postmenopausal estrogen and progestin effects on the serum proteome.. Genome medicine. 1(12):121. Abstract
Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R, Misek DE, Cooke KR, Kitko CL, Weyand A et al..  2009.  A biomarker panel for acute graft-versus-host disease.. Blood. 113(2):273-8. Abstract
2010
Prentice RL, Paczesny S, Aragaki A, Amon LM, Chen L, Pitteri SJ, McIntosh MW, Wang P, Buson Busald T, Hsia J et al..  2010.  Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling.. Genome medicine. 2(7):48. Abstract
Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V et al..  2010.  Elafin is a biomarker of graft-versus-host disease of the skin.. Science translational medicine. 2(13):13ra2. Abstract
2011
Ferrara JLM, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T, Levine JE, Choi SWJ, Huber E, Landfried K et al..  2011.  Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.. Blood. 118(25):6702-8. Abstract
2013
Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, Zhang Q, Wong C-H, Wang H, Chin A et al..  2013.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.. The New England journal of medicine. 369(6):529-39. Abstract
2014
Kitko CL, Levine JE, Storer BE, Chai X, Fox DA, Braun TM, Couriel DR, Martin PJ, Flowers ME, Hansen JA et al..  2014.  Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.. Blood. 123(5):786-93. Abstract
2015
Paczesny S, Hakim FT, Pidala J, Cooke KR, Lathrop J, Griffith LM, Hansen J, Jagasia M, Miklos D, Pavletic S et al..  2015.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(5):780-92. Abstract
Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N, Haneline LS, Robertson KA, Skiles J, Diaz-Ricart M et al..  2015.  Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(10):1739-45. Abstract
2016
Yu J, Storer BE, Kushekhar K, Abu Zaid M, Zhang Q, Gafken PR, Ogata Y, Martin PJ, Flowers ME, Hansen JA et al..  2016.  Biomarker Panel for Chronic Graft-Versus-Host Disease.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(22):2583-2590. Abstract
Liu X, Yue Z, Yu J, Daguindau E, Kushekhar K, Zhang Q, Ogata Y, Gafken PR, Inamoto Y, Gracon A et al..  2016.  Proteomic characterization reveals that MMP-3 correlates with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell and lung transplantation.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 16(8):2342-51. Abstract
Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, Choi SW, Zhang P, Greenson JK, Liu C et al..  2016.  Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.. JCI insight. 1(6) Abstract
Gea-Banacloche J, Komanduri K, Carpenter P, Paczesny S, Sarantopoulos S, Young J-A, El Kassar N, Le RQ, Schultz K, Griffith LM et al..  2016.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the Immune Dysregulation and Pathobiology Working Group Report.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, van den Brink MRM, Hansen JA, Parkman R, Miklos DB et al..  2016.  The Biology of Chronic Graft-Versus-Host Disease: a Task Force Report From the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
2017
Inamoto Y, Martin PJ, Paczesny S, Tabellini L, Momin AA, Mumaw CL, Flowers MED, Lee SJ, Carpenter PA, Storer BE et al..  2017.  Association of plasma CD163 concentration with de novo-onset chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Kanakry CG, Bakoyannis G, Perkins SM, McCurdy SR, Vulic A, Warren EH, Daguindau E, Olmsted T, Mumaw C, Towlerton AMH et al..  2017.  Plasma-derived proteomic biomarkers in HLA-haploidentical or HLA-matched bone marrow transplantation using post-transplantation cyclophosphamide.. Haematologica. Abstract
2018
Du J, Flynn R, Paz K, Ren H-G, Ogata Y, Zhang Q, Gafken PR, Storer BE, Roy NH, Burkhardt JK et al..  2018.  Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.. Blood. 131(15):1743-1754. Abstract